NASDAQ:ADGM

Adagio Medical Q2 2026 Earnings Results & Report

Adagio Medical logo
$1.75 +0.09 (+5.42%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$1.75 +0.00 (+0.11%)
As of 11/20/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Adagio Medical missed analyst earnings expectations in its Q2 2026 results, released August 11, 2026. The company reported EPS of -$9.00 versus the -$8.10 consensus estimate.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Adagio Medical EPS Results

Actual EPS
-$9.00
Consensus EPS
-$8.10
Beat/Miss
Missed by -$0.90
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 4 quarters

Adagio Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Adagio Medical Q2 2026 Earnings FAQ

Adagio Medical (NASDAQ:ADGM) reported earnings of -$9.00 per share for Q2 2026, missing the consensus estimate of -$8.10. The report was announced on Tuesday, August 11, 2026.

Adagio Medical Earnings Headlines

Adagio Medical Reports Third Quarter 2026 Results
Beyond NVDA: The World’s Next #1 Company?
This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all.tc pixel
Adagio Medical (ADGM) Expected to Post Earnings on Wednesday
ADGM - Adagio Medical Holdings, Inc.
See More Adagio Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Adagio Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adagio Medical and other key companies, straight to your email.

About Adagio Medical

Adagio Medical (NASDAQ:ADGM) is a medical technology company developing catheter-based systems for treating cardiac arrhythmias. Its technology uses ultra-low-temperature cryoablation, which applies very cold temperatures to create lesions in heart tissue that can interrupt abnormal electrical signals.

The company’s platform includes the vCLAS system, designed for ventricular arrhythmias such as ventricular tachycardia, and the iCLAS system, designed for atrial fibrillation. These systems are intended for use in catheter ablation procedures by cardiac electrophysiology teams.

View Adagio Medical Profile